首页 > 市场调查报告书 > 医疗设备

生技设备

生医光电市场规模、份额和成长分析（按技术、应用、最终用途和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1904799

生医光电市场规模、份额和成长分析（按技术、应用、最终用途和地区划分）—2026-2033年产业预测

Biophotonics Market Size, Share, and Growth Analysis, By Technology (In-Vitro, In-Vivo), By Application (See-Through imaging, Microscopy), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 186 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生医光电市场规模将达到 726.3 亿美元，到 2025 年将达到 809.1 亿美元，到 2033 年将达到 1919.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.4%。

受非侵入性诊断技术需求不断增长的推动，全球生医光电市场正经历显着成长。传统诊断方法往往存在风险和不适感，而生医光电则利用光技术进行精细的细胞分析，提供安全、精确的影像解决方案。光同调断层扫瞄（OCT）和萤光成像等技术正日益受到关注，它们能够实现疾病的早期检测和无需手术的精准治疗。此外，光电和分子成像技术的进步也增强了生医光电的能力，例如利用量子点和等离子体奈米粒子来提高癌症和阿兹海默症疾病的生物标记敏感性。随着医疗保健向更安全、更有效率的诊断方式转型，创新型生医光电技术的整合将持续扩展，从而显着推动市场发展。

生医光电市场驱动因素

非侵入性医疗技术的日益普及是生医光电市场的主要驱动力。该技术能够实现即时、高解析度成像，这对于疾病的早期检测和精准医疗的发展至关重要。随着癌症、神经系统疾病、心血管疾病和其他疾病的发生率持续上升，医疗专业人员越来越依赖生医光电解决方案。这些创新方法提供了更安全、更有效的诊断和治疗选择，改善了患者的治疗效果，并革新了医疗实践。对更先进医疗技术的需求正迅速推动生医光电的应用，进一步巩固其在现代医学中的地位。

生医光电市场限制因素

生医光电市场面临设备和基础设施成本高昂的严峻挑战。先进的光学成像系统、雷射诊断设备和生物感测器需要大量投资，这限制了它们的普及，尤其是在发展中地区。此外，这些先进技术需要专业技术人员操作，增加了实施成本。因此，资金障碍和合格人才的匮乏阻碍了生物光子学技术的应用和市场成长，使得各行各业难以充分利用生医光电解决方案的潜在优势。

生医光电市场趋势

生医光电市场正经历着由便携式和经济型诊断技术创新所驱动的显着成长趋势。像Luma Biophotonics这样的公司凭藉其利用光子积体电路（PIC）实现多分析物检测的家用分析仪，引领着这一潮流。这一趋势凸显了消费者对便利健康监测解决方案日益增长的需求，这些方案能够帮助个人积极主动地管理自身健康。聚合物PIC的出现，以更低的成本提供与之相当的光学性能，使得灵敏快速的家用检测变得更加可行。因此，生医光电有望彻底改变个人化医疗，促进疾病的早期发现，并推动预防性医疗的普及。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Carl Zeiss AG（Germany）
Olympus Corporation（Japan）
Thorlabs, Inc.（USA）
Hamamatsu Photonics KK（Japan）
Nikon Corporation（Japan）
Coherent, Inc.（USA）
PerkinElmer, Inc.（USA）
Bruker Corporation（USA）
ZEISS Group（Germany）
Horiba, Ltd.（Japan）
Photonics Industries International, Inc.（USA）
MKS Instruments, Inc.（USA）
Edmund Optics, Inc.（USA）
Jenoptik AG（Germany）

结论与建议

简介目录

Product Code: SQMIG35G2317

Biophotonics Market size was valued at USD 72.63 Billion in 2024 and is poised to grow from USD 80.91 Billion in 2025 to USD 191.91 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global biophotonics market is experiencing significant growth driven by the rising demand for non-invasive diagnostic technologies. Traditional methods often involve risks and discomfort, while biophotonics utilizes light-based approaches for detailed cellular analysis, providing safe and accurate imaging solutions. Techniques like optical coherence tomography (OCT) and fluorescence imaging are gaining traction, allowing for early disease detection and precise treatment without surgeries. Furthermore, advancements in nanophotonics and molecular imaging are enhancing the capabilities of biophotonics, including the use of quantum dots and plasmonic nanoparticles for improved biomarker sensitivity in conditions like cancer and Alzheimer's. As healthcare shifts towards safer and more efficient diagnostics, the integration of innovative biophotonics technologies will continue to expand, significantly propelling market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biophotonics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biophotonics Market Segments Analysis

Global Biophotonics Market is segmented by Technology, Application, End Use and region. Based on Technology, the market is segmented into In-Vitro and In-Vivo. Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging and Biosensors. Based on End Use, the market is segmented into Tests and Components, Medical Therapeutics, Medical Diagnostics and Non-medical Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biophotonics Market

The rising inclination towards non-invasive medical techniques significantly propels the biophotonics market. This technology facilitates real-time, high-resolution imaging, which is crucial for early disease identification and the advancement of precision medicine. As the prevalence of conditions such as cancer, neurological disorders, and cardiovascular diseases continues to escalate, healthcare professionals are increasingly turning to biophotonic solutions. These innovative methods offer safer and more effective diagnostic and treatment options, thereby enhancing patient outcomes and transforming healthcare practices. The demand for improved medical technologies is driving a surge in biophotonics applications across various medical fields, further solidifying its role in modern healthcare.

Restraints in the Biophotonics Market

The Biophotonics market faces significant challenges due to the prohibitive costs associated with devices and infrastructure. High investments are necessary for advanced optical imaging systems, laser-based diagnostics, and biosensors, which restrict their availability, particularly in developing regions. Furthermore, the operation of these sophisticated technologies requires a workforce with specialized skills, resulting in increased implementation expenses. As a result, the financial barriers and the demand for qualified personnel hinder broader adoption and market growth, making it difficult for various sectors to fully leverage the potential advantages of biophotonics solutions.

Market Trends of the Biophotonics Market

The biophotonics market is witnessing a significant trend driven by innovations in portable and affordable diagnostic technologies. Companies like Luma Biophotonics are leading the way with home-based analyzers that utilize photonic integrated circuits to deliver multianalyte testing. This trend emphasizes the growing consumer demand for accessible health monitoring solutions that empower individuals to manage their health proactively. The advent of polymeric PICs, offering comparable optical performance at lower costs, enhances the feasibility of sensitive and rapid testing at home. As a result, biophotonics is poised to revolutionize personalized healthcare, facilitating early disease detection and fostering a shift towards preventive medicine.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Biophotonics Market Size by Technology & CAGR (2026-2033)

Market Overview
In-Vitro
In-Vivo

Global Biophotonics Market Size by Application & CAGR (2026-2033)

Market Overview
See-Through imaging
Microscopy
Inside Imaging
Spectro Molecular
Analytics Sensing
Light Therapy
Surface Imaging
Biosensors

Global Biophotonics Market Size by End Use & CAGR (2026-2033)

Market Overview
Tests and Components
Medical Therapeutics
Medical Diagnostics
Non-medical Application

Global Biophotonics Market Size & CAGR (2026-2033)

North America (Technology, Application, End Use)
- US
- Canada
Europe (Technology, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Carl Zeiss AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thorlabs, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamamatsu Photonics K.K. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coherent, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEISS Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Photonics Industries International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MKS Instruments, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edmund Optics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jenoptik AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments